11:27 AM EDT, 07/10/2026 (MT Newswires) -- German lawmakers on Friday approved a bill aimed at stabilizing statutory health insurance contribution rates, forcing pharmaceutical companies to reduce drug prices. Under the approved legislation, the static manufacturer's discount for drugmakers will be increased to 15.5%, according to a same-day release from Germany's health ministry. The previous proposal in the draft bill was a dynamic manufacturer's discount. Meanwhile, the additional discount for patented vaccines will be raised to 9%, with a price freeze on immunization vaccines from Jan. 1, 2027, until Dec. 31, 2030.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.